projects
- Last Updated On :
PROJECTS
|
SL NO |
PROJECT TITLE |
FUNDING AGENCY |
DURATION |
|
1 |
Immunologic and Immunogenetic aspects of Multiple sclerosis patients in India |
ICMR |
1987 to 1990 |
| 2 |
Purine metabolic enzymes in peripheral blood T-cells in Multiple sclerosis patients |
ICMR |
1997 to 2000 |
|
Antioxidant status and genetically determined differences in xenobiotic metabolism in Parkinsons disease
|
ICMR |
1999 to 2002 |
|
Role of CYP2D6 and Glutathione S-transferase M1 (GSTM1) polymorphism in Multiple Sclerosis patients
|
ICMR |
2001 to 2003 |
|
Impact of Nutritional strategies and antioxidant therapy on progression and management of Parkinson,s disease |
ICMR |
2002 to 2004 |
|
Molecular study on mitochondrial dysfunction in Parkinson,s disease |
ICMR |
2004 to 2006 |
|
Genetic polymorphism of drug metabolizing enzymes CYPC9 and CYPC19 genes in patients developing adverse drug reactions and toxicity to specific antiepileptic drug - Phenytoin
|
ICMR |
2004 to 2007 |
|
To find out predominant mutation(s) in Cu/Zn SOD1 gene in Familial amyotrophic lateral sclerosis patients and their first –degree relatives in Indian population
|
AIIMS |
2006 to 2007 |
|
Health Profile of Population of Nellore (A.P.) An ICMR task force study. |
ICMR |
2007 to 2008 |
|
10 10 |
Analysis of TGF B Pathway components expression and mutation in glioma patients “ |
AIIMS |
2007 to 2008 |
|
11 11 |
Health Profile of Population of Dhar (MP) |
ICMR |
2009 to 2010 |
|
1 . 12 |
Pharmacogenetic of epilepsy drug therapeutics |
DBT |
2007 to 2010 |
|
13 13 |
The study of mitochondrial dysfunction in patients with Amyotrophic Lateral Sclerosis |
ICMR |
2007 to 2010 |
|
14 14 |
Validation of Gel dosimetry as 3D verification tool for highly conformal radiotherapy techniques |
AERB |
2009 to 2010 |
|
15 15 |
Exploring the role of MHC and co-stimulatory molecules in immune evasion mechanism of Glioma stem cells. |
DBT |
2008 to 2011 |
|
16 16 |
Pharmacogenetics of Alzhemiers drug therapeutics |
DST |
2010 to 2014 |
|
17 17 |
Multi centric study on Pharmacogenetics of Schizophrenia drug therapeutics |
ICMR |
2011to 2015 |
